Variant report

Variant	nsv6106
Chromosome Location	chr8:19499554-19544249
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:786)
CpG islands
(count:733)
Chromatin interactive
region (count:18)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:786 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr8:19522209-19523419	HepG2	liver:	n/a	n/a
2	ARID3A	chr8:19518754-19519207	HepG2	liver:	n/a	n/a
3	ARID3A	chr8:19521131-19521509	HepG2	liver:	n/a	n/a
4	ATF3	chr8:19520892-19521495	A549	lung:	n/a	n/a
5	ATF3	chr8:19518727-19518888	HepG2	liver:	n/a	n/a
6	ATF3	chr8:19535329-19536527	A549	lung:	n/a	n/a
7	ATF3	chr8:19522705-19523526	A549	lung:	n/a	n/a
8	ATF3	chr8:19535318-19536344	A549	lung:	n/a	n/a
9	ATF3	chr8:19522737-19523482	A549	lung:	n/a	n/a
10	ATF3	chr8:19499332-19499995	A549	lung:	n/a	n/a
11	BCL3	chr8:19520726-19521628	A549	lung:	n/a	n/a
12	BCL3	chr8:19522216-19523653	A549	lung:	n/a	chr8:19523104-19523113
13	BCL3	chr8:19535244-19536549	A549	lung:	n/a	n/a
14	BCL3	chr8:19499144-19500243	A549	lung:	n/a	n/a
15	BCL3	chr8:19522261-19523415	A549	lung:	n/a	chr8:19523104-19523113
16	BCL3	chr8:19535097-19536789	A549	lung:	n/a	n/a
17	BDP1	chr8:19536515-19536816	Hela-S3	cervix:	n/a	n/a
18	BHLHE40	chr8:19518717-19519016	HepG2	liver:	n/a	n/a
19	BHLHE40	chr8:19519719-19519894	GM12878	blood:	n/a	n/a
20	BHLHE40	chr8:19539963-19539997	GM12878	blood:	n/a	n/a
21	BRCA1	chr8:19535497-19536695	Hela-S3	cervix:	n/a	n/a
22	BRCA1	chr8:19522860-19523313	Hela-S3	cervix:	n/a	n/a
23	BRCA1	chr8:19520948-19521466	Hela-S3	cervix:	n/a	n/a
24	BRCA1	chr8:19518717-19519045	Hela-S3	cervix:	n/a	n/a
25	CBX3	chr8:19518617-19519104	HCT-116	colon:	n/a	n/a
26	CEBPB	chr8:19517164-19517396	A549	lung:	n/a	n/a
27	CEBPB	chr8:19522210-19523329	Hela-S3	cervix:	n/a	n/a
28	CEBPB	chr8:19520331-19520728	Hela-S3	cervix:	n/a	n/a
29	CEBPB	chr8:19521042-19521473	A549	lung:	n/a	n/a
30	CEBPB	chr8:19508784-19508971	A549	lung:	n/a	n/a
31	CEBPB	chr8:19499483-19499943	MCF-7	breast:	n/a	chr8:19499652-19499663
32	CEBPB	chr8:19522905-19523214	HepG2	liver:	n/a	n/a
33	CEBPB	chr8:19517100-19517405	Hela-S3	cervix:	n/a	n/a
34	CEBPB	chr8:19521066-19521936	IMR90	lung:	n/a	n/a
35	CEBPB	chr8:19518720-19519047	HepG2	liver:	n/a	n/a
36	CEBPB	chr8:19522922-19523135	K562	blood:	n/a	n/a
37	CEBPB	chr8:19499617-19499817	HepG2	liver:	n/a	chr8:19499652-19499663
38	CEBPB	chr8:19499477-19499971	Hela-S3	cervix:	n/a	chr8:19499652-19499663
39	CEBPB	chr8:19499472-19499960	IMR90	lung:	n/a	chr8:19499652-19499663
40	CEBPB	chr8:19535399-19536763	A549	lung:	n/a	chr8:19536554-19536565
41	CEBPB	chr8:19544228-19544963	IMR90	lung:	n/a	n/a
42	CEBPB	chr8:19522671-19523462	HCT-116	colon:	n/a	n/a
43	CEBPB	chr8:19518722-19519162	A549	lung:	n/a	n/a
44	CEBPB	chr8:19499557-19499830	MCF-7	breast:	n/a	chr8:19499652-19499663
45	CEBPB	chr8:19522239-19522697	A549	lung:	n/a	n/a
46	CEBPB	chr8:19522836-19523305	HepG2	liver:	n/a	n/a
47	CEBPB	chr8:19522290-19522625	HepG2	liver:	n/a	n/a
48	CEBPB	chr8:19520956-19521941	Hela-S3	cervix:	n/a	n/a
49	CEBPB	chr8:19522088-19523685	A549	lung:	n/a	n/a
50	CEBPB	chr8:19535444-19536834	Hela-S3	cervix:	n/a	chr8:19536554-19536565

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:19540396-19540446	GM19239	blood:	n/a
2	chr8:19540396-19540446	GM19239	blood:	n/a
3	chr8:19540479-19540529	CMK	blood:	n/a
4	chr8:19540396-19540446	HMEC	breast:	n/a
5	chr8:19540466-19540516	HMEC	breast:	n/a
6	chr8:19504047-19504097	HCT-116	colon:	n/a
7	chr8:19540479-19540529	GM06990	blood:	n/a
8	chr8:19540479-19540529	HAEpiC	amniotic membrane:	n/a
9	chr8:19539991-19540041	HEEpiC	esophagus:	n/a
10	chr8:19540576-19540626	Hela-S3	cervix:	n/a
11	chr8:19540210-19540260	NHBE	bronchial:	n/a
12	chr8:19520584-19520634	ECC-1	luminal epithelium:	n/a
13	chr8:19540479-19540529	T-47D	breast:	n/a
14	chr8:19540479-19540529	HCPEpiC	choroid plexus:	n/a
15	chr8:19540396-19540446	ovcar-3	ovarian:	n/a
16	chr8:19536244-19536294	SK-N-SH	brain:	n/a
17	chr8:19540479-19540529	SKMC	muscle:	n/a
18	chr8:19540479-19540529	SK-N-SH_RA	brain:	n/a
19	chr8:19540396-19540446	NT2-D1	testis:	n/a
20	chr8:19540466-19540516	ECC-1	luminal epithelium:	n/a
21	chr8:19540453-19540503	HRPEpiC	eye:	n/a
22	chr8:19536244-19536294	HepG2	liver:	n/a
23	chr8:19540734-19540784	IMR90	lung:	fetal
24	chr8:19536244-19536294	HRE	kidney:	n/a
25	chr8:19540466-19540516	Caco-2	colon:	n/a
26	chr8:19540210-19540260	HepG2	liver:	n/a
27	chr8:19536244-19536294	NHBE	bronchial:	n/a
28	chr8:19520584-19520634	MCF-7	breast:	n/a
29	chr8:19504047-19504097	AG10803	skin:	n/a
30	chr8:19540453-19540503	HCM	heart:	n/a
31	chr8:19540466-19540516	MCF-7	breast:	n/a
32	chr8:19540453-19540503	BE2_C	brain:	n/a
33	chr8:19540734-19540784	HCM	heart:	n/a
34	chr8:19540466-19540516	PrEC	prostate:	n/a
35	chr8:19540576-19540626	HCF	heart:	n/a
36	chr8:19540210-19540260	MCF-7	breast:	n/a
37	chr8:19540272-19540322	SK-N-SH_RA	brain:	n/a
38	chr8:19536244-19536294	PANC-1	pancreas:	n/a
39	chr8:19540576-19540626	LNCaP	prostate:	n/a
40	chr8:19520584-19520634	GM12891	blood:	n/a
41	chr8:19520584-19520634	SK-N-MC	brain:	n/a
42	chr8:19539991-19540041	Jurkat	blood:	n/a
43	chr8:19540453-19540503	NHDF-neo	bronchial:	n/a
44	chr8:19504047-19504097	AG09319	gingival:	n/a
45	chr8:19540466-19540516	HCM	heart:	n/a
46	chr8:19540396-19540446	HCT-116	colon:	n/a
47	chr8:19536244-19536294	HUVEC	blood vessel:	n/a
48	chr8:19540453-19540503	HEEpiC	esophagus:	n/a
49	chr8:19540466-19540516	GM12891	blood:	n/a
50	chr8:19540466-19540516	HIPEpiC	eye:	n/a

(count:18 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:19536477..19540083-chr8:19612902..19617470,5	MCF-7	breast:
2	chr8:19535157..19537582-chr8:19537640..19539899,3	MCF-7	breast:
3	chr8:19517559..19519398-chr8:19521074..19523001,2	MCF-7	breast:
4	chr8:19535666..19538060-chr8:19539355..19541920,2	K562	blood:
5	chr8:19530467..19533341-chr8:19540692..19542563,2	K562	blood:
6	chr3:122134415..122135096-chr8:19535842..19536586,2	Hela-S3	cervix:
7	chr8:19534323..19537317-chr8:19613839..19616648,2	MCF-7	breast:
8	chr8:19535486..19538060-chr8:19539195..19541920,3	K562	blood:
9	chr8:19521485..19523580-chr8:19526746..19529079,2	MCF-7	breast:
10	chr8:19523263..19525014-chr8:19530361..19532867,2	MCF-7	breast:
11	chr8:19521485..19523580-chr8:19526746..19529079,2	MCF-7	breast:
12	chr8:19497421..19499586-chr8:19613571..19616001,2	MCF-7	breast:
13	chr8:19535486..19538060-chr8:19539195..19541920,3	K562	blood:
14	chr8:19535666..19538060-chr8:19539355..19541920,2	K562	blood:
15	chr8:19523263..19525014-chr8:19530361..19532867,2	MCF-7	breast:
16	chr8:19147589..19149540-chr8:19523160..19524664,2	MCF-7	breast:
17	chr8:19517559..19519398-chr8:19521074..19523001,2	MCF-7	breast:
18	chr8:19528114..19529694-chr8:19534657..19537045,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-INTS10-2	chr8:19536105-19536338	NONHSAT125382
2	lnc-PSD3-3	chr8:19540439-19540751	NONHSAT125377
3	lnc-INTS10-2	chr8:19536083-19536338	ENSG00000253270

No data

Variant related genes	Relation type
CSGALNACT1	TF binding region
ENSG00000253270	TF binding region
CSGALNACT1	CpG island
ENSG00000253270	CpG island
ENSG00000196981	chromatin interactions
ENSG00000147408	chromatin interactions
ENSG00000272758	chromatin interactions
ENSG00000253270	chromatin interactions

Extended variants
information (count: 2531 )
Associated
traits (count: 117 )

Variant overlapped rSNPs/rCNVs (count:2531 , 50 per page) page: 1 2 3 4 5 6 7 ... 51

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2975426	chr8:19499575-19499576	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs555702720	chr8:19499588-19499589	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs575386330	chr8:19499597-19499598	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs537957273	chr8:19499613-19499614	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs374353626	chr8:19499614-19499615	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs557871740	chr8:19499627-19499628	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs577712857	chr8:19499646-19499647	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs371607285	chr8:19499668-19499669	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs2957623	chr8:19499674-19499675	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs17128770	chr8:19499722-19499723	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
11	rs181822197	chr8:19499757-19499758	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs546440817	chr8:19499801-19499802	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs369530111	chr8:19499831-19499832	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs542860924	chr8:19499833-19499834	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs562553146	chr8:19499862-19499863	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs34634230	chr8:19499885-19499886	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs186434621	chr8:19499910-19499911	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs372904598	chr8:19499943-19499944	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs545224475	chr8:19499951-19499952	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs577609815	chr8:19499979-19499980	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs199600823	chr8:19499994-19499995	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs2957625	chr8:19500001-19500002	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs190735268	chr8:19500013-19500014	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs527363245	chr8:19500021-19500022	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs376389283	chr8:19500025-19500026	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs139128895	chr8:19500042-19500043	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs529562416	chr8:19500046-19500047	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs2979876	chr8:19500068-19500069	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs558512830	chr8:19500120-19500121	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs149962580	chr8:19500169-19500170	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs180928705	chr8:19500171-19500172	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs2957626	chr8:19500183-19500184	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs538097065	chr8:19500190-19500191	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs2979877	chr8:19500226-19500227	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs545425362	chr8:19500233-19500234	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs557908827	chr8:19500252-19500253	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs571424552	chr8:19500291-19500292	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs200931060	chr8:19500300-19500301	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs186158296	chr8:19500301-19500302	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs534271818	chr8:19500303-19500304	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs575896695	chr8:19500322-19500323	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs191503305	chr8:19500387-19500388	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs573939601	chr8:19500405-19500406	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs145038948	chr8:19500409-19500410	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs182905661	chr8:19500505-19500506	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs532069370	chr8:19500522-19500523	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs576385665	chr8:19500580-19500581	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs371955978	chr8:19500615-19500616	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs545261252	chr8:19500625-19500626	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs117026322	chr8:19500628-19500629	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:117)

Disease	PMID	Source
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Prostate cancer	21965145	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Colorectal cancer	16272173	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Seminomas	18059402	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Myxofibrosarcoma	16751306	CNVD
Immune disease	21572526	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Kallmann Syndrome 2	22470819	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Epilepsy	22083797	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	16461572	CNVD
Breast cancer	17603634	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	17550852	CNVD
Pancreatic cancer	21811587	CNVD
Multiple myeloma	16461302	CNVD
Developmental delay	21373258	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21364760	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cancer	18840272	CNVD
Breast cancer	19602461	CNVD
Osteosarcoma	19286668	CNVD
Prostate cancer	19242612	CNVD
Prostate cancer	19258508	CNVD
small cell lung cancer	20016488	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Gastric adenocarcinoma	19115996	CNVD
Colorectal cancer	19455253	CNVD
Prostate cancer	22341455	CNVD
Lung adenocarcinoma	21935476	CNVD
Breast cancer	22522925	CNVD
Melanoma	20688739	CNVD

Chromatin state (count:992 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:19482000-19520000	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
2	chr8:19485400-19500000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr8:19488800-19501200	Weak transcription	Primary T helper naive cells from peripheral blood	blood
4	chr8:19489800-19500000	Weak transcription	Lung	lung
5	chr8:19495600-19500400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr8:19495800-19500200	Enhancers	Primary neutrophils fromperipheralblood	blood
7	chr8:19495800-19508600	Weak transcription	Primary T cells from cord blood	blood
8	chr8:19496000-19501200	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
9	chr8:19496000-19502400	Weak transcription	Primary T helper cells PMA-I stimulated	--
10	chr8:19496000-19503000	Weak transcription	Pancreas	Pancrea
11	chr8:19496000-19503000	Weak transcription	Right Atrium	heart
12	chr8:19496000-19503000	Weak transcription	Spleen	Spleen
13	chr8:19496000-19504200	Weak transcription	Right Ventricle	heart
14	chr8:19496200-19500200	Enhancers	Cortex derived primary cultured neurospheres	brain
15	chr8:19496200-19502600	Weak transcription	Primary T helper cells fromperipheralblood	blood
16	chr8:19496800-19501600	Weak transcription	Primary B cells from cord blood	blood
17	chr8:19496800-19501800	Weak transcription	Primary hematopoietic stem cells	blood
18	chr8:19497000-19499600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
19	chr8:19497600-19500400	Flanking Active TSS	A549	lung
20	chr8:19497600-19502800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
21	chr8:19497800-19500400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr8:19497800-19501600	Weak transcription	Primary B cells from peripheral blood	blood
23	chr8:19498200-19500400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
24	chr8:19498200-19501600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr8:19498200-19508200	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
26	chr8:19498400-19500400	Enhancers	Monocytes-CD14+_RO01746	blood
27	chr8:19498400-19500400	Enhancers	NHLF	lung
28	chr8:19498600-19499600	Enhancers	Fetal Brain Male	brain
29	chr8:19498600-19500400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
30	chr8:19498600-19501000	Enhancers	Primary monocytes fromperipheralblood	blood
31	chr8:19498800-19500200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr8:19498800-19500400	Enhancers	Muscle Satellite Cultured Cells	--
33	chr8:19498800-19500400	Enhancers	HepG2	liver
34	chr8:19498800-19500400	Enhancers	NH-A	brain
35	chr8:19499000-19500000	Enhancers	Brain Hippocampus Middle	brain
36	chr8:19499000-19500000	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
37	chr8:19499000-19500000	Weak transcription	Left Ventricle	heart
38	chr8:19499200-19499600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
39	chr8:19499200-19499600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr8:19499200-19499600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
41	chr8:19499200-19499600	Flanking Active TSS	Hela-S3	cervix
42	chr8:19499200-19499600	Flanking Active TSS	NHDF-Ad	bronchial
43	chr8:19499200-19499600	Flanking Active TSS	Osteobl	bone
44	chr8:19499200-19500200	Enhancers	Brain Cingulate Gyrus	brain
45	chr8:19499200-19500200	Enhancers	Brain Inferior Temporal Lobe	brain
46	chr8:19499200-19500200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
47	chr8:19499200-19500400	Enhancers	Fetal Lung	lung
48	chr8:19499200-19500400	Enhancers	HMEC	breast
49	chr8:19499200-19500400	Enhancers	HUVEC	blood vessel
50	chr8:19499200-19501800	Enhancers	Brain Substantia Nigra	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links